Clinical Trends for October 2016

Ryan Syrek

Disclosures

October 28, 2016

Clinical Trend of the Week (October 8-14): Kratom Ban

A ban that never was resulted in this week's top search term. The US Drug Enforcement Agency (DEA) had announced intent to designate the herbal supplement kratom a schedule I drug by September 30. However, that decision was delayed after some kratom users and researchers joined members of Congress in expressing concern about proceeding without public input. A petition signed by more than 140,000 people urged the White House to avoid the new scheduling. No doubt, the passionate outcry garnered the attention of clinicians, resulting in this week's top search.

For info on herb poisoning, read here.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....